These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 38804138)

  • 1. Skeletal Muscle SIRT3 Deficiency Contributes to Pulmonary Vascular Remodeling in Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction.
    Jheng JR; Bai Y; Noda K; Huot JR; Cook T; Fisher A; Chen YY; Goncharov DA; Goncharova EA; Simon MA; Zhang Y; Forman DE; Rojas M; Machado RF; Auwerx J; Gladwin MT; Lai YC
    Circulation; 2024 Sep; 150(11):867-883. PubMed ID: 38804138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma Proteomics Identifies B2M as a Regulator of Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction.
    Jheng JR; DesJardin JT; Chen YY; Huot JR; Bai Y; Cook T; Hibbard LM; Rupp JM; Fisher A; Zhang Y; Duarte JD; Desai AA; Machado RF; Simon MA; Lai YC
    Arterioscler Thromb Vasc Biol; 2024 Jul; 44(7):1570-1583. PubMed ID: 38813697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SIRT3-AMP-Activated Protein Kinase Activation by Nitrite and Metformin Improves Hyperglycemia and Normalizes Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction.
    Lai YC; Tabima DM; Dube JJ; Hughan KS; Vanderpool RR; Goncharov DA; St Croix CM; Garcia-Ocaña A; Goncharova EA; Tofovic SP; Mora AL; Gladwin MT
    Circulation; 2016 Feb; 133(8):717-31. PubMed ID: 26813102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LOXL2 inhibition ameliorates pulmonary artery remodeling in pulmonary hypertension.
    Steppan J; Wang H; Nandakumar K; Gadkari M; Poe A; Pak L; Brady T; Berkowitz DE; Shimoda LA; Santhanam L
    Am J Physiol Lung Cell Mol Physiol; 2024 Oct; 327(4):L423-L438. PubMed ID: 39010824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early Alteration of Right Ventricle-Pulmonary Artery Coupling in Experimental Heart Failure With Preserved Ejection Fraction.
    Hubesch G; Dewachter C; Chomette L; Hupkens E; Jespers P; Vegh G; Doppler M; Sheikh Mohammad U; Thiriard A; Remmelink M; Vachiéry JL; McEntee K; Dewachter L
    J Am Heart Assoc; 2024 Jun; 13(11):e032201. PubMed ID: 38780193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sirtuin 3 deficiency does not augment hypoxia-induced pulmonary hypertension.
    Waypa GB; Osborne SW; Marks JD; Berkelhamer SK; Kondapalli J; Schumacker PT
    Am J Respir Cell Mol Biol; 2013 Dec; 49(6):885-91. PubMed ID: 24047466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary vascular disease in the setting of heart failure with preserved ejection fraction.
    Levine AR; Simon MA; Gladwin MT
    Trends Cardiovasc Med; 2019 May; 29(4):207-217. PubMed ID: 30177249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting MuRF1 by small molecules in a HFpEF rat model improves myocardial diastolic function and skeletal muscle contractility.
    Adams V; Schauer A; Augstein A; Kirchhoff V; Draskowski R; Jannasch A; Goto K; Lyall G; Männel A; Barthel P; Mangner N; Winzer EB; Linke A; Labeit S
    J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1565-1581. PubMed ID: 35301823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysyl oxidases play a causal role in vascular remodeling in clinical and experimental pulmonary arterial hypertension.
    Nave AH; Mižíková I; Niess G; Steenbock H; Reichenberger F; Talavera ML; Veit F; Herold S; Mayer K; Vadász I; Weissmann N; Seeger W; Brinckmann J; Morty RE
    Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1446-58. PubMed ID: 24833797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into the pulmonary vascular complications of heart failure with preserved ejection fraction.
    Lai YC; Wang L; Gladwin MT
    J Physiol; 2019 Feb; 597(4):1143-1156. PubMed ID: 30549058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel insights into the pathobiology of pulmonary hypertension in heart failure with preserved ejection fraction.
    Aradhyula V; Vyas R; Dube P; Haller ST; Gupta R; Maddipati KR; Kennedy DJ; Khouri SJ
    Am J Physiol Heart Circ Physiol; 2024 Jun; 326(6):H1498-H1514. PubMed ID: 38639739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIMF (Hypoxia-Induced Mitogenic Factor) Signaling Mediates the HMGB1 (High Mobility Group Box 1)-Dependent Endothelial and Smooth Muscle Cell Crosstalk in Pulmonary Hypertension.
    Lin Q; Fan C; Gomez-Arroyo J; Van Raemdonck K; Meuchel LW; Skinner JT; Everett AD; Fang X; Macdonald AA; Yamaji-Kegan K; Johns RA
    Arterioscler Thromb Vasc Biol; 2019 Dec; 39(12):2505-2519. PubMed ID: 31597444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Sex-Specific Role of Endothelial Sirtuin 3 on Blood Pressure and Diastolic Dysfunction in Female Mice.
    Zeng H; He X; Chen JX
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33371209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of Titin and Contraction-Regulating Proteins in a Rat Model of Heart Failure with Preserved Ejection Fraction: Limb vs. Diaphragmatic Muscle.
    Vahle B; Heilmann L; Schauer A; Augstein A; Jarabo MP; Barthel P; Mangner N; Labeit S; Bowen TS; Linke A; Adams V
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment With Treprostinil and Metformin Normalizes Hyperglycemia and Improves Cardiac Function in Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction.
    Wang L; Halliday G; Huot JR; Satoh T; Baust JJ; Fisher A; Cook T; Hu J; Avolio T; Goncharov DA; Bai Y; Vanderpool RR; Considine RV; Bonetto A; Tan J; Bachman TN; Sebastiani A; McTiernan CF; Mora AL; Machado RF; Goncharova EA; Gladwin MT; Lai YC
    Arterioscler Thromb Vasc Biol; 2020 Jun; 40(6):1543-1558. PubMed ID: 32268788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a Mouse Model of Metabolic Syndrome, Pulmonary Hypertension, and Heart Failure with Preserved Ejection Fraction.
    Meng Q; Lai YC; Kelly NJ; Bueno M; Baust JJ; Bachman TN; Goncharov D; Vanderpool RR; Radder JE; Hu J; Goncharova E; Morris AM; Mora AL; Shapiro SD; Gladwin MT
    Am J Respir Cell Mol Biol; 2017 Apr; 56(4):497-505. PubMed ID: 28118022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced pulmonary vasodilator reserve and abnormal right ventricular: pulmonary artery coupling in heart failure with preserved ejection fraction.
    Andersen MJ; Hwang SJ; Kane GC; Melenovsky V; Olson TP; Fetterly K; Borlaug BA
    Circ Heart Fail; 2015 May; 8(3):542-50. PubMed ID: 25857307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial Heterogeneity in the Response to Autophagy Drives Small Vessel Muscularization in Pulmonary Hypertension.
    Zhang Q; Yaoita N; Tabuchi A; Liu S; Chen SH; Li Q; Hegemann N; Li C; Rodor J; Timm S; Laban H; Finkel T; Stevens T; Alvarez DF; Erfinanda L; de Perrot M; Kucherenko MM; Knosalla C; Ochs M; Dimmeler S; Korff T; Verma S; Baker AH; Kuebler WM
    Circulation; 2024 Aug; 150(6):466-487. PubMed ID: 38873770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global Pulmonary Vascular Remodeling in Pulmonary Hypertension Associated With Heart Failure and Preserved or Reduced Ejection Fraction.
    Fayyaz AU; Edwards WD; Maleszewski JJ; Konik EA; DuBrock HM; Borlaug BA; Frantz RP; Jenkins SM; Redfield MM
    Circulation; 2018 Apr; 137(17):1796-1810. PubMed ID: 29246894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial Sirtuin 3 Dictates Glucose Transport to Cardiomyocyte and Sensitizes Pressure Overload-Induced Heart Failure.
    Zeng H; He X; Chen JX
    J Am Heart Assoc; 2020 Jun; 9(11):e015895. PubMed ID: 32468895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.